GEN9, INC.

Profile

Company Names

GEN9, INC.

Addresses

840 MEMORIAL DRIVE, FIFTH FLOOR, CAMBRIDGE, MA 01239

500 TECHNOLOGY SQUARE, CAMBRIDGE, MA 02139

500 TECHNOLOGY SQUARE, SUITE #130, CAMBRIDGE, MA 01239

20 MCTERNAN ST, APT. 208, CAMBRIDGE, MA 02215

Phone Numbers

617-250-8433
608 213 6567

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$50,400,001.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2014-07-25 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
5
2013-04-22 
$21,000,000.00 
$21,000,000.00 
$0.00 
Equity 
4
2012-05-18 
$395,000.00 
$2,000,000.00 
$1,605,000.00 
Debt 
3
2011-08-25 
$1,550,001.00 
$9,591,568.00 
$8,041,567.00 
Equity 
2
2010-11-15 
$1,955,000.00 
$2,500,000.00 
$545,000.00 
Debt 
1
2009-06-01 
$500,000.00 
$2,000,000.00 
$1,500,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JENNIFER 
 
CAMACHO 
EXECUTIVE OFFICER
GEN9, INC.
FRANCO 
 
CERRINA 
DIRECTOR, EXECUTIVE OFFICER
GEN9, INC.
GEORGE 
 
CHURCH 
DIRECTOR, PROMOTER
GEN9, INC.   |  KENDALL CAPITAL PARTNERS I, L.P.   |  ASTROMECH AI CORP.
NEIL 
 
COOK 
DIRECTOR
GEN9, INC.
WALI 
 
DAI 
DIRECTOR
GEN9, INC.
WEILI 
 
DAI 
DIRECTOR
GEN9, INC.   |  LARK TECHNOLOGIES, INC.   |  FLC GLOBAL, LTD.   |  CAPSOVISION, INC   |  GRAVEL INC.   |  WOLLEY, INC.   |  ASTRANA HEALTH, INC.
DREW 
 
ENDY 
DIRECTOR, PROMOTER
GEN9, INC.
MARTIN 
 
GOLDBERG 
EXECUTIVE OFFICER
GEN9, INC.
JAMES 
 
HOLLENHORST 
DIRECTOR
GEN9, INC.
JIM 
 
HOLLENHORST 
DIRECTOR
GEN9, INC.
JOSEPH 
 
JACOBSON 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
GEN9, INC.   |  KOVIO INC   |  IGC BIO INC.
STEPHEN 
 
JURVETSON 
DIRECTOR
GEN9, INC.   |  FLUX FACTORY, INC.   |  VANNEVAR TECHNOLOGY, INC.
PAUL 
 
MANNING 
DIRECTOR
GEN9, INC.   |  ENZYMATICS INC   |  AVEXIS, INC.   |  VERRICA PHARMACEUTICALS INC.   |  ARCHERDX, INC.   |  ADVANTAGENE, INC.   |  TOLERION, INC.   |  BLUE MARLIN THERAPEUTICS, INC.
KEVIN 
 
MUNNELLY 
EXECUTIVE OFFICER, DIRECTOR
GEN9, INC.
STANLEY 
 
ROSE 
DIRECTOR
GEN9, INC.   |  CELLULAR DYNAMICS INTERNATIONAL, INC.   |  BLUEPAC DELILAH, LP   |  BLUEPAC GWEN LP   |  BLUEPAC FRAN LP   |  BLUEPAC EVELYN LP   |  FAB FIVE NO 1 LP   |  BLUEPAC KATY LP   |  FAB FIVE NO 2 LP   |  BLUEPAC MARY, LP   |  FAB FIVE #7 LP   |  TRANSPLANT GENOMICS INC.   |  NOWATA PRODUCTION PARTNERSHIP LP   |  URBAN 8 LLC
BILL 
 
SCALZULLI 
DIRECTOR
GEN9, INC.
SCOTT 
 
SCHOEN 
DIRECTOR
GEN9, INC.
LAWRENCE 
 
SILVERSTEIN 
EXECUTIVE OFFICER
NODAL EXCHANGE LLC   |  GEN9, INC.
DAVID 
 
STONE 
EXECUTIVE OFFICER
NEXT TO NORMAL LLC   |  INVIZEON CORP   |  FORMATION CAPITAL CORP   |  SOUTHERN ARC MINERALS INC   |  TRUMARX DATA PARTNERS INC   |  TRUMARX DATA PARTNERS, INC.   |  FORMATION CAPITAL CORP /FI   |  FORMATION METALS INC   |  FORMATION METALS INC   |  TOSCA MINING CORP   |  HILLCREST RESOURCES LTD   |  SUPERIOR MINING INTERNATIONAL CORP   |  SEAHORSE BIOSCIENCE INC   |  NORTHSTAR BANKING CORP   |  CYTRELLIS BIOSYSTEMS, INC.   |  GEN9, INC.   |  HILLCREST PETROLEUM LTD.   |  FACE TO FACE BROADWAY LLC   |  HAROLD-S BIRTHDAY LLC   |  FORAGER1, INC.   |  TRANSFORMATIVEMED INC.
JACOB 
 
THAYSEN 
DIRECTOR
GEN9, INC.
JEREMY 
 
WERTHEIMER 
DIRECTOR
GEN9, INC.   |  IGC BIO INC.   |  AMIDE TECHNOLOGIES, INC.   |  SYNLIFE, INC.
AARON 
 
ZUCKER 
EXECUTIVE OFFICER
GEN9, INC.   |  FABRIC GLOBAL, PBC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-07-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-25 
2013-05-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-22 
2012-05-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-05-18 
2011-09-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-25 
2011-04-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-11-15 
2011-02-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-11-15 
2009-06-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#